Vanguard Group Inc Ionis Pharmaceuticals Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 16,383,934 shares of IONS stock, worth $531 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,383,934
Previous 16,472,539
0.54%
Holding current value
$531 Million
Previous $576 Million
14.17%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding IONS
# of Institutions
401Shares Held
146MCall Options Held
916KPut Options Held
552K-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$525 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$401 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$335 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$273 Million0.05% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$255 Million5.5% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.6B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...